V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20146362 | 20134367 | 1.59 | 66.8 | null | 2020-05-23 | 2020-05-23 | ECarboX | null | N | GEMCITABINE + TEYSUNO | 100714816 |
| 20146423 | 20134368 | 1.81 | 84.2 | Palliative (P) | 2017-04-19 | 2019-01-31 | CHOP R - 21 days | 01 | null | SCOPE 1 TRIAL | 101120411 |
| 20146817 | 20134369 | 1.72 | 56.7 | null | 2020-04-29 | 2020-05-04 | Hydroxycarbamide | null | N | BENDAMUSTINE + RITUXIMAB | 101014132 |
| 20147061 | 20134370 | 1.71 | null | Curative (C) | 2020-05-21 | 2020-06-19 | CYCLO + DOXORUBICIN + VINCRISTINE | N | N | CARBOPLATIN + PEMETREXED | 101498959 |
| 20147170 | 20134371 | 1.51 | 59.55 | 03 | null | 2017-01-26 | GEFITINIB | 01 | N | TEMOZOLOMIDE | 101789225 |
| 20147197 | 20134372 | 1.87 | 69.8 | Neo-adjuvant (N) | null | 2018-03-25 | EVEROLIMUS + LENVATINIB | null | N | CISPLATIN + FLUOROURACIL + STREPTOZOCIN | 100843358 |
| 20147238 | 20134373 | 1.8 | 53 | null | null | 2019-09-15 | CARBOPLATIN + VINORELBINE | Y | null | HYDROXYCARBAMIDE | 100388128 |
| 20147403 | 20134374 | 1.69 | 84 | Palliative (P) | 2016-05-02 | 2016-05-14 | EEF or EOF | 02 | N | IRINOTECAN + MDG + PANITUMUMAB | 100772465 |
| 20147523 | 20134375 | 1.55 | null | Neo-adjuvant (N) | 2018-11-03 | 2018-11-19 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 01 | null | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101375847 |
| 20148059 | 20134377 | 1.52 | 94 | null | null | 2020-02-12 | RUXOLITINIB | N | N | CYCLOPHOSPHAMIDE + FLUDARABINE + RITUXIMAB | 100347012 |
| 20148182 | 20134378 | 1.8 | 72.3 | null | 2018-11-11 | 2018-11-13 | CAPECITABINE + IRINOTECAN + Panitumumab | 02 | null | RUXOLITINIB | 101627462 |
| 20148325 | 20134379 | 1.77 | 72.3 | Curative (C) | 2021-05-17 | 2021-05-24 | CAPECITABINE + NIVOLUMAB + OXALIPLATIN | 02 | N | CAPECITABINE + CETUXIMAB + OXALIPLATIN | 101071880 |
| 20148558 | 20134380 | 1.65 | 104 | Curative (C) | 2019-10-13 | 2019-10-14 | ECarboX | null | N | ETOPOSIDE | 101213518 |
| 20148640 | 20134381 | 0 | 131.2 | Curative (C) | 2020-07-30 | 2021-05-28 | BENDAMUSTINE + RITUXIMAB | N | N | GEMCARBO | 100605586 |
| 20148788 | 20134382 | 1.54 | 102.1 | Palliative (P) | 2017-03-30 | 2017-03-30 | GemCarbo Days 1+8 | N | null | AZACITIDINE | 100907601 |
| 20149019 | 20134383 | 1.7 | null | Adjuvant (A) | 2019-08-03 | 2019-08-08 | Cisplatin + Docetaxel +Fluorouracil | N | N | DASATINIB | 101631269 |
| 20149178 | 20134384 | 1.77 | 48.3 | Curative (C) | 2018-07-29 | 2018-07-30 | PHITT D SIOPEL-4 (A1, A2, A3) | 02 | null | GEMCITABINE + OXALIPLATIN | 101299694 |
| 20149286 | 20134385 | 1.71 | 74 | Palliative (P) | 2019-02-09 | 2019-03-07 | Cisplatin + Vinorelbine (IV) | 02 | Y | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101393517 |
| 20149311 | 20134386 | 1.8 | 14.1 | Palliative (P) | 2018-06-01 | 2018-06-05 | GEMCITABINE + TEGAFUR | 02 | N | OSIMERTINIB | 101059622 |
| 20149386 | 20134387 | 1.72 | 68.5 | null | 2020-03-30 | 2020-04-14 | ETOPOSIDE | 02 | null | ENCORAFENIB | 100119472 |
| 20149394 | 20134388 | 1.64 | 70 | Disease modification (D) | null | 2020-06-28 | PHITT C SIOPEL-3HR | 2 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100234040 |
| 20149423 | 20134389 | 1.56 | 72 | Palliative (P) | null | 2019-08-06 | LIPOSOMAL DAUNORUBICIN + CYTARABINE (Vyxeos) | N | N | RUCAPARIB | 101183253 |
| 20149597 | 20134390 | 1.53 | 53.3 | null | 2018-06-13 | 2018-06-13 | GEMCITABINE + TEGAFUR | null | null | MITOMYCIN | 101611825 |
| 20149655 | 20134391 | 1.71 | 65.8 | Curative (C) | 2018-01-30 | 2018-02-03 | Gemcitabine + Oxaliplatin | N | null | CARBOPLATIN + VINORELBINE | 100089119 |
| 20149786 | 20134392 | 1.65 | 80.2 | 03 | 2019-12-18 | 2019-12-21 | Bevacizumab + CAPECITABINE + OXALIPLATIN | 02 | N | RADIUM 223 | 100288536 |
| 20149841 | 20134393 | 1.57 | 73.4 | Palliative (P) | 2018-09-23 | 2018-11-03 | Bendamustine+Rituximab(Sub Courses) | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + VINCRISTINE | 100178999 |
| 20150028 | 20134394 | 1.53 | 55.6 | null | 2017-09-27 | 2017-10-12 | CISPLATIN + TEYSUNO | 02 | N | COSMIC TRIAL | 100847809 |
| 20150073 | 20134396 | 1.84 | 56.8 | null | 2020-11-15 | 2020-12-04 | Doxorubicin + Olaratumab | 02 | null | HYDROXYCARBAMIDE | 101262778 |
| 20150228 | 20134397 | 1.65 | 46.8 | null | 2016-08-14 | 2016-08-23 | Atezolizumab | 02 | N | CAPECITABINE + CARBOPLATIN + RT | 101395167 |
| 20150397 | 20134398 | 1.59 | 93.5 | Adjuvant (A) | 2016-12-19 | 2017-01-06 | ANAGRELIDE | 02 | N | ECARBOX | 100562011 |
| 20150426 | 20134399 | 1.92 | 94 | Curative (C) | 2021-08-09 | 2021-08-10 | Temozolomide 150mg/m2 | 02 | N | CAPECITABINE + STREPTOZOCIN | 101312898 |
| 20150567 | 20134400 | 2 | 46.15 | Disease modification (D) | 2019-06-08 | 2019-06-08 | CAPECITABINE + NIVOLUMAB + OXALIPLATIN | 99 | N | GEMCITABINE + OXALIPLATIN | 100608568 |
| 20150592 | 20134401 | 0 | 18.5 | Palliative (P) | 2016-10-17 | 2016-10-18 | PHITT D Carboplatin / doxorubicin . | 02 | N | CAP + RT | 101539347 |
| 20150806 | 20134402 | 1.57 | 53 | Palliative (P) | null | 2017-11-15 | BENDAMUSTINE + THALIDOMIDE | null | N | ATEZOLIZUMAB | 101564629 |
| 20150859 | 20134403 | 1.9 | 81.1 | null | 2021-06-08 | 2021-06-16 | Capecitabine + Streptozocin | 02 | null | ARISTOTLE TRIAL | 101533733 |
| 20150915 | 20134404 | 1.8 | 88.4 | Palliative (P) | 2019-12-21 | 2019-12-23 | MITOMYCIN | N | N | SCOPE2 TRIAL | 101319846 |
| 20151260 | 20134405 | 1.65 | 60.85 | Palliative (P) | 2021-07-27 | 2021-08-04 | CAPE + OXALIPLATIN + TRASTUZUMAB | 02 | N | IXAZOMIB + LENALIDOMIDE | 100393145 |
| 20151283 | 20134406 | 1.69 | null | Palliative (P) | 2020-01-30 | 2020-02-05 | IRINOTECAN + MDG + PANITUMUMAB | N | null | IRINOTECAN + MDG + PANITUMUMAB | 100745172 |
| 20151823 | 20134408 | 1.76 | 103 | Palliative (P) | 2018-08-25 | 2018-08-26 | Lomustine | N | N | BACILLUS CALMETTE-GUERIN | 100679599 |
| 20151919 | 20134409 | 1.86 | 44.8 | Palliative (P) | 2018-06-11 | 2018-06-15 | Hydroxycarbamide | N | Y | GEMCARBO | 100567508 |
| 20151921 | 20134410 | 1.75 | 61.1 | 03 | 2019-03-13 | 2020-04-12 | SCOPE 2 TRIAL | 02 | N | MELPHALAN | 100126165 |
| 20152027 | 20134411 | 1.52 | 55.3 | Palliative (P) | 2018-03-28 | 2018-03-28 | Atezolizumab | null | null | NAB-PACLITAXEL | 100420980 |
| 20152039 | 20134412 | 1.82 | 59.7 | Palliative (P) | 2018-10-20 | 2018-11-08 | ETOPOSIDE | 02 | N | OXALIPLATIN + MDG + PANITUMUMAB | 100775652 |
| 20152042 | 20134413 | 1.82 | 69.8 | Palliative (P) | 2018-02-07 | 2018-02-17 | TEMOZOLOMIDE | 02 | N | STREPTOZOCIN + MDG | 100555245 |
| 20152086 | 20134414 | 1.53 | 62.2 | Neo-adjuvant (N) | null | 2017-03-09 | null | 1 | N | CISPLATIN + FLUOROURACIL + RT | 100729830 |
| 20152400 | 20134416 | 1.72 | 71 | null | 2019-09-02 | 2019-09-10 | Hepatoblastoma SR Cisplatin | 02 | N | CAPECITABINE + STREPTOZOCIN | 100926943 |
| 20152813 | 20134417 | 0 | null | Palliative (P) | null | 2021-05-04 | IBRUTINIB | 01 | n | CYCLOPHOSPHAMIDE + EPIRUBICIN + FLUOROURACIL | 100598057 |
| 20152822 | 20134418 | 1.75 | 42 | Curative (C) | 2018-02-24 | 2018-03-01 | FCarboSt | 02 | null | CISPLATIN + RT | 101137819 |
| 20152894 | 20134419 | 1.42 | 87.1 | Palliative (P) | 2017-07-07 | 2017-10-09 | Arsenic trioxide + Tretinoin | 02 | N | BORTEZOMIB + DARATUMUMAB | 100961916 |
| 20153102 | 20134420 | 1.77 | 67.6 | Palliative (P) | 2018-01-31 | 2018-02-01 | Cisplatin + Pemetrexed | 02 | N | CAP + RT | 100467017 |